JACC. Cardiovascular interventions
-
JACC Cardiovasc Interv · Mar 2015
Randomized Controlled Trial Multicenter Study Comparative StudyOutcomes with cangrelor versus clopidogrel on a background of bivalirudin: insights from the CHAMPION PHOENIX (A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention [PCI]).
The aim of this study was to examine the efficacy and bleeding outcomes of cangrelor in patients in the CHAMPION PHOENIX (A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention [PCI]) who underwent percutaneous coronary intervention with bivalirudin. ⋯ Cangrelor may offer an attractive benefit risk profile when used in combination with bivalirudin.